Granules India Limited is an Indian pharmaceutical company, founded by C. Krishna Prasad. Granules is a large-scale, fully backward integrated formulation manufacturer which partners with market leaders to provide products throughout the pharmaceutical value chain. The Company manufactures Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) which are distributed in over 50 countries.
Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large-scale for customers in the regulated and semi-regulated markets.
There has been an aggressive promoter buying seen in the counter in past 6 months or so. Also, the founder of the company, C Krishna Prasad has released nearly 14 Lakhs Shares from Pledge in past 3 months, which is a great, great confidence booster for investors.
Stock Price Estimates:
This is one stock where I feel that even when the stock has risen from 55-60 levels in Dec 2011 to 230-235 in Sept 2012, it is still not late to enter the script as I expect the price to touch 250-290 very soon, mostly within next 3 quarters.
Further I expect the stock to go on increasing with time, till it reaches 4 digits.
According to the information that I have from company's management, it is expected that Granules India will be a 5000 Cr Revenue company by 2017 from 500 Cr Revenue company today.
As per the report declared by the company, they expect Q2 and Q3 of Fiscal Year (FY) 2013 to be the breakout quarters for their company. Lets invest and hope for the best.
Disclosure:
I have invested heavily in this company and have a good number of shares at an avg price of 139. But, still, I expect everyone to do their own research and consulting before investing in the company.
